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A B S T R A C T
DNA-based individual identiﬁcation and RNA-based tissue identiﬁcation represent two commonly-used
tools in forensic investigation, aiming to identify crime scene sample donors and helping to provide links
between DNA-identiﬁed sample donors and criminal acts. Currently however, both analyses are typically
performed separately. In this proof-of-principle study, we developed an approach for the simultaneous
analysis of forensic STRs, amelogenin, and forensic mRNAs based on parallel targeted DNA/RNA
sequencing using the Ion Torrent Personal Genome Machine1 (PGMTM) System coupled with the
AmpliSeqTM targeted ampliﬁcation. We demonstrated that 9 autosomal STRs commonly used for
individual identiﬁcation (CSF1PO, D16S539, D3S1358, D5S818, D7S820, D8S1179, TH01, TPOX, and vWA),
the AMELX/AMELY system widely applied for sex identiﬁcation, and 12 mRNA markers previously
established for forensic tissue identiﬁcation (ALAS2 and SPTB for peripheral blood,MMP10 andMMP11 for
menstrual blood, HTN3 and STATH for saliva, PRM1 and TGM4 for semen, CYP2B7P1 andMUC4 for vaginal
secretion, CCL27 and LCE1C for skin) together with two candidate reference mRNA markers (HPRT1 and
SDHA) can all be successfully combined. UnambiguousmRNA-based tissue identiﬁcationwas achieved in
all samples from all forensically relevant tissues tested, and STR sequencing analysis of the tissue sample
donors was 100% concordant with conventional STR proﬁling using a commercial kit. Successful STR
analysis was obtained from 1ng of genomic DNA and mRNA analysis from 10ng total RNA; however,
sensitivity limits were not investigated in this proof-of-principle study and are expected to be much
lower. Since dried materials with noticeable RNA degradation and small DNA/RNA amplicons with high-
coverage sequencing were used, the achieved correct individual and tissue identiﬁcation demonstrates
the suitability of this approach for analyzing degraded materials in future forensic applications. Overall,
our study demonstrates the feasibility of simultaneously obtaining multilocus STR, amelogenin, and
multilocus mRNA information for combined individual and tissue identiﬁcation from a small sample of
degraded biological material. Moreover, our study marks the ﬁrst step towards combining many DNA/
RNA markers for various forensic purposes to increase the effectiveness of molecular forensic analysis
and to allow more forensically relevant information to be obtained from limited forensic material.
ã 2015 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Human identiﬁcation from DNA via comparative STR proﬁling
has become a standard tool in forensic laboratories around the
world [1]. However, the DNA-identiﬁed donor of a crime scene
sample not necessarily is the perpetrator. One piece of information
that helps linking (or not) identiﬁed sample donors with criminal
acts, is to ﬁnd out which type of cells or tissue, such as saliva,
peripheral and menstrual blood, semen, vaginal secretion, and
skin, was used for STR proﬁling and thus individual identiﬁcation
[2]. In fact, after STR-based individual identiﬁcation, establishing
the cellular origin of biological traces found at crime scenes is
considered the next crucial task in forensic casework, as it allows
for the reconstruction of the sequence of crime events and
evaluation of the relevance of forensic evidences. Therefore,
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forensic investigators require tools for unequivocal, conﬁrmatory
proof of the origin of biological stains used for STR proﬁling, which
can be defended in court.
In recent years, progress in forensicmolecular biology has led to
the development of RNA-based methods for forensic tissue
identiﬁcation [3–5]. Multiple RNA markers were proposed for all
forensically relevant tissues, some of them were evaluated in
collaborative trials to identify the most informative and robust
mRNA markers out of many suggested previously [6–13]. Notably,
unlike most of the previous forensic methods used for forensic
tissue identiﬁcation that are often presumptive, prone to false
positive or false negative results, and destructive to biological
samples, the RNA approach allows for sensitive, speciﬁc, non-
destructive and parallel identiﬁcation of the cellular origin of
biological traces [3]. Whereas the information upon the cellular
origin of crime scene biological samples is typically obtained from
RNA, individual identiﬁcation of the donors of these samples is
established from DNA, typically using STRs and sometimes SNPs.
Currently, these two types of molecular analyses, DNA and RNA
testing, are typically performed separately. However, in the future
both analyses may want to be joined, especially with the
perspective to combine with more DNA/RNA markers for
additional forensic purposes to increase the effectiveness of
molecular forensic analysis and to allowmore forensically relevant
information to be obtained from limited crime scene material.
In principle, massive parallel sequencing (MPS), also referred to
next generation sequencing (NGS) or second generation sequenc-
ing (SGS), allows the targeted analysis of large numbers of nucleic
acidmarkers including DNA and (after a reverse transcription step)
RNA markers, which is not feasible with alternative technologies
that only allow limited multiplexing. Currently, NGS platforms
such as the Ion TorrentTM Personal Genome Machine1 (PGMTM)
and others have been already applied to forensic STR [16–18] and
SNP analysis [19–21] for human identiﬁcation purposes. They are
also used for forensic research purposes and suitability testing for
future case work applications of mitochondrial DNA analysis for
high-resolution maternal lineage identiﬁcation [14,15]. Recently,
we demonstrated that the parallel analysis of >500 Y-SNPs
covering the entire currently known Y-chromosome phylogenetic
tree is feasible in a single analysis with the Ion TorrentTM PGMTM
for providing ultra-high resolution paternal lineage and ancestry
information [16]. The combined analysis of different types of
forensic biomarkers (DNA and RNA) for different forensic purposes
with NGS platforms has not been demonstrated as of yet and was
noted to be difﬁcult in a recent review article on forensic NGS [17].
Here, we present a proof-of-principle study on parallel analysis
ofmultiple STRmarkers, amelogenin, andmultiplemRNAmarkers,
and demonstrate that in principle combined individual and tissue
identiﬁcation is feasable using targeted NGS, particularly with the
Ion Torrent PGM.
2. Materials and methods
2.1. Sample collection
A total of 7 volunteers including 4male and 3 female individuals
donated their body ﬂuids for this study under informed consent.
Native peripheral blood samples were obtained with ﬁnger pricks,
and blood drops were absorbed by sterile cotton swabs.
Unstimulated saliva was obtained by spitting into 50mL Falcon
tubes, aliquotswere pipetted onto cotton swabs. Freshly ejaculated
semen was collected in plastic cups, and then aliquotted onto
cotton swabs. Semen-free vaginal secretions and menstrual blood
were collected using sterile cotton-tipped swabs from volunteers
who had abstained from sexual contact for a minimum of three
days. Menstrual blood was collected at 3rd day of menstruation.
The same donors contributed the menstrual blood and vaginal
secretion samples. All cotton swabs were allowed to slowly dry at
room temperature for at least overnight and stored at 80 C until
the isolation of nucleic acids. Skin samples were obtained from
surgical left-over biopsymaterial (for sample description see [18]).
The epidermal layer of the skinwas removed from the dermal layer
by ﬁrst cutting the skin into pieces of 1mmwide and 7mm long
and incubating the skin pieces for 30min at room temperature in
ammonium thiocyanate solution (3.8% ATC in PBS) [19].
2.2. Preparation of nucleic acids
RNA and DNAwere co-isolated from the same biological sample
using AllPrep Kit (Qiagen) according to the manufacturer’s
protocol. RNA fraction was treated with Turbo DNase Kit from
Ambion (Applied Biosystems, Netherlands) to remove traces of
genomic DNA. The quality and quantity of RNA were assessed by
capillary electrophoresis on Agilent 2100 Bioanalyzer automated
analysis system (Agilent Technologies, Palo Alto, CA, USA).
Genomic DNA concentrations were established with Quantiﬁler1
Human DNAQuantiﬁcation Kit (Applied Biosystems, Netherlands).
2.3. mRNA and STR sequencing
Twelve mRNAmarkers (2 per each tissue) previously suggested
for tissue identiﬁcation, as well as 2 house-keeping genes serving
as positive controls were analyzed (Table 1). Ion AmpliSeq
Designer software tool (Thermo Fisher) was used to design a
panel of custom PCR primers producing the amplicons of average
size 150bp. Ion AmpliSeqTM RNA Library Kit 2.0 was used for RNA
Table 1
Primers formRNAmarkers used for tissue identiﬁcation in combinationwith STR/amelogenin sequencingwith the Ion Torrent PGM. All primers were automatically designed
by AmpliSeq Designer software to span the intron, but not exon–exon boundaries.
mRNA marker Targeted tissue Forward Reverse Reference
HPRT1 House-keeping TTCCTCCTCCTGAGCAGTCA ACCCTTTCCAAATCCTCAGCAT [20]
SDHA House-keeping TTGAGATTTGCTGATGGAAGCATAAGA GTGCTTTAGGTCTCCATAGAGCTT [20]
MMP10 Menstrual blood CCATAAGGAAAATTGATGCAGCTGTT CAACTCCTGGAAAGTCATCAGCTA [7]
MMP11 Menstrual blood GACGCCACTCACCTTTACTGA TCCCCTTCTCGGTGAGTCTT [7]
ALAS2 Peripheral blood GACCCTGACCACCTAAAGAAACTT GAAGGTCAGGGCCCCATAC [9]
SPTB Peripheral blood CTAGTGGACACGGCGGATAA GATGCCCTGGTGATACTTCATGAG [9]
HTN3 Saliva TCAACGTGTTTAAATACATCAGCCATCT AGCATGAGAGCCAAGATTAAAGCAA [8]
STATH Saliva GTATGGCCCTTATCAGCCAGTT TGGATGTAGAAGTCGTATTTGCCAATC [8]
PRM1 Semen GCAGATATTACCGCCAGAGACA AGGAGTTTGGTGGATGTGCTATTTT [8]
TGM4 Semen AAATGTCCTGGACTGCTGCAT CCCCAGTCCAATTCCCAATGAG [8]
CCL27 Skin GACTGTCACCTCCAGGCTTT TCCTTAGCATCCCAAAATTCAGCTT [13]
LCE1C Skin GTCTCTTCCTGCTGCAGTGT TCTGTGGCAGTGGGACCTA [13]
CYP2B7P1 Vaginal secretion GAATTCAGCCACCAGAACCTCAT CACCTGTTCAATCTCCTTGTAGACT [7]
MUC4 Vaginal secretion GAATGACAAGCCCTACCTCTGT CCCAGCCCATTGAAGGTGTA [7]
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library preparation according to manufacturer’s instructions.
Standard protocol for RNA library preparations includes 20 cycles
of PCR ampliﬁcation, which was used here. Before combination in
multiplex analysis, all mRNA markers were tested via singleplex
analysis using all tissue samples (targeted and non-targeted ones).
Singleplex analysis revealed much higher number of sequencing
reads for the target mRNA markers in the targeted tissue samples
(i.e., for bloodmRNAmarkers in blood samples etc.) than in all non-
targeted samples (data not shown), as we expected from
previously established marker knowledge. Because it is well
known thatmenstrual blood and vaginal secretion samples contain
large amounts of non-human mRNA, which compromises total
RNA measurements, we also tested 30 cycles of ampliﬁcation in
these samples to overcome the problem of insufﬁcient human RNA
content in these samples. Although we found that with 30 cycles
the number of sequencing reads was increased, as expected, in the
ﬁnal multiplexing analyses we used the standard protocol of
20 cycles.
Nine forensic autosomal STRs commonly used for individual
identiﬁcation (CSF1PO, D16S539, D3S1358, D5S818, D7S820,
D8S1179, TH01, TPOX, and vWA) as well as AMELX/AMELY locus
for sex determination (Table 2), i.e., the Ion TorrentTM HID STR
10-plex (Life Technologies), were ampliﬁed by PCR in 20-ul
reactions containing 8ul of 2.5X Thermo Fisher Proprietary
Reaction Mix 2ul of 10X Primer Mix (STR 10-plex Ion AmpliseqTM
primer panel) and 1ng DNA unless speciﬁed differently. The PCR
conditions were 95 C for 1min, followed by 30 cycles of 94 C for
10 s and 59 C for 90 s with a ﬁnal hold time of 5min at 60 C.
Primers were partially digested by adding 2ul of FuPa reagent (Ion
AmpliSeqTM Library Kit 2.0) to the PCR reaction, and incubated at
50 C for 10min, 55 C for 10min followed by 60 C for 20min.
Samples were then puriﬁed using 40ul AMPure XP Reagent
(Agencourt1) following the recommended protocol and was then
eluted in 74ul EB buffer (10mM Tris–HCl pH 8.0). DNA library was
prepared using Ion Plus Fragment Library Kit based on the
manufacturer’s instructions. Libraries were quantiﬁed using the
Ion Quantitation Kit then diluted, and ﬁnally pooled in equimolar
ratios. The libraries were processed with the Ion OneTouchTM
2 System using Ion PGMTM Template OT2 200 Kit to produce
200 base-read libraries. Sequencing of the libraries was performed
with Ion Torrent PGM using 318 v2 chips and Ion PGMTM
200 Sequencing Kit v2. Sequencing was performed as suggested
by the manufacturer with the small adjustment of the increased
number of ﬂows from 500 to 750.
Firstly, separate sequencing runswere performed formRNA and
STR marker panels to test their performance for each sample. For
the subsequent ﬁnal multiplex experiments RNA and DNA libraries
from the same sample were individually barcoded with Ion
XpressTM Barcode Adapters 1-96 Kit. Both cDNA and genomic DNA
libraries were pooled in equal amounts and simultaneously
processed with the Ion OneTouchTM 2 System using Ion PGMTM
Template OT2 200 Kit to produce 200 base-read libraries.
Sequencing of the libraries was performed with Ion Torrent
PGM using ver. 318 chips v2 and Ion PGMTM 200 Sequencing Kit v2.
In singlemachine run up to 16 barcoded samples (8 RNA and 8 STR)
were sequenced simultaneously. In accordance to manufacturer’s
protocols, 1 ng genomic DNA and 10ng total RNA were used as
templates. The only difference between singleplex and multiplex
experiments was that for the latter we combined differently
barcoded samples (DNA and RNA) fromdifferent individuals in one
sequencing run. Therefore, multiplex sequencing may be consid-
ered as a technical replication of singleplex experiments.
STR sequencing results obtained with Ion Torrent PGM were
veriﬁed for concordance with classical capillary electrophoresis
(CE) based genotyping using AmpFLSTR1 Identiﬁler1 PCR
Ampliﬁcation Kit (Thermo Fisher), which contained all 9 STR
markers and the amelogenin system used here for Ion Torrent PGM
sequencing.
2.4. Data analysis
Sequencing results were analyzedwith Ion Torrent Suite v.4.0.1.
Mapped sequencing reads for mRNA targets were counted with
Coverage Analysis plugin v. 4.2. STR proﬁling was performed with
HID_STR_Genotyper v.2.0. RNA-based tissue classiﬁcation was
performed with binary logistic regression analysis using IBM SPSS
Statistics v. 21 software.
3. Results and discussion
3.1. Sample issues: mRNA integrity
In vitro stability of mRNA markers is an essential prerequisite
for their use in forensic applications [5]. Current methods of
mRNA-based tissue identiﬁcation that mostly include end-point
PCR followed by capillary electrophoresis are capable of successful
analysis of even highly degraded samples [4]. To motivate future
forensic use on degraded samples, in this proof-of-principle study,
we used body ﬂuid samples that were allowed to air-dry slowly on
cotton swabs under room temperature, and are therefore expected
to have undergone some RNA degradation. The result of the
Bioanalyzer testing of RNA integrity indeed conﬁrm that the
samples we used for Ion Torrent PGM sequencing were compro-
mised as shown in Fig. 1. However, despite the noticeable RNA
degradation, tissue identiﬁcation was successful for all samples
tested. Our preliminary data suggest that the use of small cDNA
amplicons of 150 bp for all 14 mRNA markers provides suitable
prerequisites for successful analysis of degraded RNA, raising
reasonable expectations that our approach will be suitable for the
analysis of forensic casework samples, whichwill need to be tested
in detailed future studies.
3.2. Sample issues: human mRNA quantity
Particular biological ﬂuids, i.e., vaginal secretion and menstrual
blood, are naturally contaminated with bacteria. Therefore, total
RNA concentration measurements with Bioanalyzer, or any other
conventional methods that are all based on the overall content of
RNA (human and non-human), do not accurately reﬂect the
content of human RNA in such samples. Likely because of this, we
found in the singleplex mRNA pre-testing that some of the vaginal
secretion and menstrual blood samples tested revealed lower
numbers of sequencing reads than samples from other tissues
(data not shown). One way to compensate for this problemwould
be increasing the total input amount of the RNA template;
however, this is not always possible in forensic casework.
Table 2
GRCh37/hg19 genomic coordinates of forensic STRs and amelogenin (BED ﬁle)
included in the Ion Torrent HID 10plex system used for human identiﬁcation in
combination with mRNA sequencing with the Ion Torrent PGM.
Locus Chromosome Start End
AMELX chrX 11315050 11315050
AMELY chrY 6737935 6737935
CSF1PO chr5 149455886 149455937
D16S539 chr16 86386308 86386351
D3S1358 chr3 45582229 45582292
D5S818 chr5 123111250 123111293
D7S820 chr7 83789542 83789593
D8S1179 chr8 125907105 125907156
TH01 chr11 2192318 2192345
TPOX chr2 1493425 1493456
vWA chr12 6093143 6093210
124 D. Zubakov et al. / Forensic Science International: Genetics 17 (2015) 122–128
Therefore, in the preliminarily mRNA singleplex testing we
increased the number of AmpliSeq PCR cycles during sequencing
library preparation. Instead of 20 PCR cycles recommended in the
standard manufacturer’s protocol, we used 30 cycles of ampliﬁca-
tion for vaginal secretion and menstrual blood samples. As
expected, this small change in protocol resulted into an increase
of sequencing reads without noticeable negative effect on
sequencing accuracy (data not shown). However, in the ﬁnal
multiplex analysis and regardless of the sample used (see below)
the application of 20 cycles did provide accurate tissue identiﬁca-
tion for all samples tested, including those from vaginal secretion
and menstrual blood. Nevertheless, our pretesting results suggest
that for the future practical application of the method, any
unknown sample which fails to amplify during the library
preparation using the standard protocol (i.e., 20 cycles) shall be
repeated with an increased number of ampliﬁcation cycles (i.e.,
30). Notably, failure with the standard protocol in future
applications could be because of the presence of vaginal and
menstrual blood samples due to the human/non-humanRNAeffect
described above, or due to any other human forensic samples with
limited amounts of human RNA for simple quantity reasons.
3.3. Sequencing quality issues
Quality control of PGM sequencing runs (data not shown)
indicated that only about half of the sequencing reads were usable.
Apparently this indicates that our sequencing runs were not ideal
as compared to theoretically achievable number of usable reads.
However, this did not prevent the successful tissue identiﬁcation
with the mRNA markers used or obtaining the correct STR proﬁles
(see below) likely because of the relatively small number of DNA/
RNA markers and of pooled barcoded samples included in our
experiments relative to the overall sequencing capacity of the chips
used. If many more DNA and RNA markers will be included in the
multiplex sequencing including those for other forensic purposes,
this may become an issue. Objective quality metrics have yet to be
established via additional future work.
3.4. Ion Torrent PGMmRNA proﬁling for tissue identiﬁcation purposes
The results of mRNA sequencing using multiplex analysis of all
RNA markers and together with amelogenin and 9 STRs revealed
that the tissue-targeting mRNA markers constitute the vast
majority of sequencing reads in each of the target tissues in all
samples tested (Fig. 1), except for certain cases of naturally mixed
body ﬂuids, e.g., one of the twomenstrual blood samples used. The
tissue speciﬁcity of all mRNAmarkers testedwas very high; almost
all of the markers in non-target tissues were either not expressed
or expressed extremely low compared to the target tissues
(Suppl. Table 1).
[(Fig._1)TD$FIG]
Fig. 1. BioAnalyzer gel electrophoresis exemplifying the degree of RNA degradation
of the samples used in the current study. The #2–6 – RNA samples were isolated
from different body ﬂuids that were air-dried under room temperature: peripheral
blood, vaginal secretion, menstrual blood, semen, and saliva, respectively, while the
#1 RNA sample was isolated from skin biopsy material. L: size standard.
[(Fig._2)TD$FIG]
Fig. 2. Results of Ion Torrent PGM sequencing of tissue-speciﬁc mRNA markers (expressed as relative number of sequencing reads per each sample) as performed
simultaneously together with STR/amelogenin sequencing.
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Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.fsigen.2015.04.002.
Body ﬂuids that naturally contain cells of mixed biological
origin such as menstrual blood demonstrated the presence of
multiple makers; along with menstrual blood speciﬁc genes
(MMP10 and MMP11), blood and vaginal secretion markers were
also present. Given the intrinsic heterogeneity of this particular
body ﬂuid, the observed variability in the relative abundance of
markers in different samples is to be expected. One of two analyzed
menstrual blood samples (#2) revealed a higher vaginal secretion
component (likely picked-up during sampling procedure) than the
other menstrual blood sample tested (#1) as indicated by the high
number of sequencing reads for MUC4 and CYP2B7P1. This not
surprising as ﬁnding vaginal secretion as well as peripheral blood
mRNAmarkers in menstrual blood was observed before [7,21–23].
However, the presence of speciﬁcmenstrual bloodmarkersMMP11
andMMP10 (Fig 2, Suppl. Table 1) does allow its correct assignment
to menstrual blood. In general, unambiguous, 100% accurate tissue
identiﬁcation was achieved in all cases as conﬁrmed by binary
regression analysis. As shown in Table 3, every individual mRNA
marker used appeared to be highly speciﬁc for its target tissuewith
the exception of CYP2B7P1, which seems to be not signiﬁcantly
speciﬁc for vaginal secretion due to the natural presence of vaginal
mucosa in menstrual blood. However, when vaginal secretion and
menstrual blood are combined together and compared versus
other tissues, CYP2B7P1 appeared as highly signiﬁcant classiﬁer
(score 7.421, p-value 0.006).
Given the small sample size in our proof-of-principle study, the
statistical power of the classiﬁcation with logistic regression
should not be overestimated. Important to stress here, our
experiments corroborate existing knowledge upon the respective
tissue speciﬁcity of the selected mRNA markers, which was
established in previous works based on larger number of samples
using alternative technologies. This includes the mRNA markers
LCE1C and CCL27 and their speciﬁcity for skin samples obtainable
from forensically relevant touched objects/contact traces [24],
while in the present study we used skin biopsy samples for
technical reasons. However, the limited samples used in this proof-
of-principle study, together with previously established marker
knowledge, proved the suitability of the Ion Torrent PGM platform
for forensic tissue identiﬁcation purpose, which should be tested
on more samples in more detailed future studies.
In addition to the 12 tissue-speciﬁc mRNAmarkers, two house-
keeping genes, SDHA and HPRT1, were included. These genes were
selected from the published list of reference gene candidates
recommended for PCR normalization [20]. However, they were
never thoroughly tested in the forensic context as of yet. Therefore,
using these genes for normalization in ourwork is only provisional.
At the current stage of research, we consider using these house-
keeping genes as positive controls rather than proper normalizers,
as no difference was observed between the normalized and raw
data, in terms of speciﬁcity of any particular marker (Suppl.
Table 1). Missing normalization protocol potentially may compli-
cate the interpretation of the results of mixed stains analysis,
which however appears to be very challenging with any currently
available method of tissue identiﬁcation using RNA markers
[25,26]. Future additional work on the housekeeping genes used
here will determine their use as reference genes for normalization
purposes.
Theoretically, the sensitivity of the mRNA proﬁling with Ion
Torrent PGM sequencing should not be much different from the
regular qRT-PCR analysis, since AmpliSeq ampliﬁcation of mRNA
targetsworks by the sameprinciple. Thorough sensitivity testing of
the method is the topic for future studies; however, even the
currently used 10ng of total RNA per reaction is in the range of
usability in practical forensic casework and can possibly be
lowered.
3.5. Ion Torrent PGM STR and amelogenin proﬁling for individual
identiﬁcation purposes
In total 7 individuals, who provided their tissue samples for this
project, were sequenced at 9 forensic STRs and AMELY/AMELX
simultaneously (Table 2) and together with the 14 mRNAs
described above using the Ion Torrent PGM. In our hands and
for the samples tested, the Ion TorrentTM HID STR 10-plex protocol
Table 3
Binary logistic regression analysis of 12mRNAmarkers used for tissue identiﬁcation as carried out in combinationwith STR/amelogenin sequencingwith the IonTorrent PGM.
Signiﬁcant markers are highlighted in bold.
Marker Blood Menstrual blood Saliva Semen Skin Vaginal secretion
Score p-value Score p-value Score p-value Score p-value Score p-value Score p-value
SPTB 9.274 .002 .366 .545 .373 .541 .373 .542 .369 .544 .374 .541
ALAS2 11.583 .001 .400 .527 .480 .488 .480 .488 .479 .489 .480 .488
MMP11 .185 .667 5.461 .019 .229 .632 .208 .648 .234 .629 .238 .626
MMP10 .230 .631 5.728 .017 .225 .636 .230 .631 .230 .631 .230 .631
STATH .445 .505 .445 .505 11.124 .001 .445 .505 .445 .505 .445 .505
HTN3 .422 .516 .420 .517 10.537 .001 .422 .516 .422 .516 .422 .516
TGM4 .329 .566 .329 .566 .329 .566 8.190 .004 .322 .571 .329 .566
PRM1 .333 .564 .335 .563 .334 .563 8.355 .004 .335 .563 .335 .563
CCL27 .394 .530 .394 .530 .394 .530 .390 .532 9.836 .002 .395 .530
LCE1C .209 .647 .889 .346 .006 .936 .598 .439 9.880 .002 .793 .373
CYP2B7P1 .757 .384 3.077 .079 .696 .404 .757 .384 .762 .383 2.866 .090
MUC4 .761 .383 .159 .690 .648 .421 .760 .383 .752 .386 9.110 .003
Table 4
STR microvariants detected by STR sequencing carried out in combination with amelogenin and mRNA sequencing with the Ion Torrent PGM.
STR marker/allele Variant 1 Variant 2 Variant 3
D3S1358-16 [TATC]2[TGTC]1[TATC]13 [TATC]2[TGTC]2[TATC]12 [TATC]2[TGTC]3[TATC]11
D3S1358-17 [TATC]2[TGTC]2[TATC]13 [TATC]2[TGTC]3[TATC]12
D8S1179-15 [TATC]2[TGTC]1[TATC]12 [TATC]3[TGTC]1[TATC]11
vWA-14 [TAGA]9[CAGA]4[TAGA]1 [TAGA]3[TGGA]1[TAGA]3[CAGA]4[TAGA]1[CAGA]1[TAGA]1
vWA-15 [TAGA]10[CAGA]4[TAGA]1 [TAGA]11[CAGA]3[TAGA]1
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used here worked without any technical problems. Data analysis
plugin HID_STR_Genotyper allowed fast and easy calling of STR
allelles as well as of amelogenin alleles. Concordance testing of Ion
Torrent STR proﬁng with conventional capillary electrophoresis
performed with AmpFLSTR1 Identiﬁler1 PCR Ampliﬁcation Kit
which includes all 10 loci, revealed no length allele differences
between the two methods (Suppl. Fig. 1).
Supplementary material related to this article found, in the
online version, at http://dx.doi.org/10.1016/j.fsigen.2015.04.002.
The added value of sequencing STRs such aswith the IonTorrent
PGM lies in the detection of repeat motif variations that do not
result in length variation, as previously demonstrated for the Ion
TorrentTMHID STR 10-plex protocol and for the IonTorrent PGMwe
used here [27]. Such microvariants have the potential to provide
additional resolution needed, for example in complex mixed stain
analysis. In our limited set of 7 samples, we found such
microvariants at 3 out of the 9 STR markers analyzed, namely at
D3S1358, D8S1179, and vWA (Table 4). Notably, there was one
sample that when considering only the repeat length appeared to
be homozygote for D3S1358 with 16 repeats, but in fact it was
heterozygote because of a single point mutation in one of the
repeat blocks. When more samples will be sequenced, many more
repeat motif variants are expected to be found, which adds power
to the discriminating capacity of STRs in general.
For STR/amelogenin sequencing, we used 1ng of genomic DNA
as recommended by the manufacturer. Performing detailed
sensitivity testing goes beyond the purpose of the presented
proof-of-principle study; however, it is expected that the
sensitivity of STR proﬁling with Ion Torrent PGM will be higher
than shownhere. Recently [27], a sensitivity threshold of 50pgwas
reported for the Ion TorrentTM HID STR 10-plex protocole including
the same 9 forensic STRs and amelogenin that we applied here in
combination with mRNA markers. Future sensitivity testing will
determine if this high STR sequencing sensitivity level is also
achievable when combined with mRNA sequencing as done here.
3.6. Simultaneous mRNA and STR proﬁling with Ion Torrent PGM
In the current protocol, we started from the very same
biological sample and ﬁnished with the very same sequencing
run for STR, amelgoenin, and mRNA markers simultaneously;
however, we had to split the DNA and RNA sample preparation
steps in between. This was necessary because the current version
of the RNA AmpliSeq pipeline used here does not allow to
completely avoid the ampliﬁcation of genomic DNA with the
mRNA/cDNA primers. In fact, for some mRNA markers tested we
noted ampliﬁcation from genomic DNA (data not shown) with the
primers used, which motivated us to separate the DNA and RNA
sample preparation steps. However, ongoing developments are
aimed to solve this problemvia intelligent primer design, so that in
the future all steps are expected to be done simultaneously.
In our experiments, we found that simultaneous sequencing of
up to 16 barcoded samples (8 DNA and 8 RNA samples) caused no
deleterious effect on both mRNA or STR proﬁling; apparently, the
capacity of the Ion Torrent chip 318 v.2 allowsmuch higher level of
multiplicity, which shall be explored more in future studies.
All experiments in this study were carried out from single
source samples and the investigation of mixed samples will be a
matter of future detailed studies. As discussed elsewhere [28],
correct tissue identiﬁcation frommixed stain material is challeng-
ing with any method currently used, especially as long as
appropriate methods to quantify human RNA prior to analysis
are missing. This in principle also applies to NGS-based methods
that however, have the advantage that the results are quantiﬁed
directly (in contrast to currently used CE-based methods) via
counting of sequencing reads. This is expected to improve mixed
stain analysis in general and has already been demonstrated for
forensic STR and SNP analysis in preliminary studies [27,29] with
more work needed.
Previously, the analysis of STRs and a small number of miRNAs
ampliﬁed from the same sample via separated PCR via a combined
CE-based approach was proposed [30,31]. However, limitations in
the type and number of miRNA markers used did not allow the
identiﬁcation of all forensically relevant tissues as we achieved
here via combined NGS. Furthermore, the traditional CE-approach
provides strong limitations to the total number of D/RNA markers
combinable in the end-point reading due to limitations in
fragment-size length spacing and the limited number of available
ﬂuorescence dyes. Unlike previous approaches, NGS such as via the
Ion Torrent PGM used here, in principle allows simultaneous
analysis of large numbers (many hundreds up to several
thousands) of genetic markers as for instance we previously
demonstrated for >500 Y-SNPs [16]. The PGM-based NGS tool for
combined STR/amelogenin/mRNA analysis for simultaneous indi-
vidual and tissue identiﬁcation that we introducedwith this proof-
of-principle study serves as a starting point and we envision
adding many more genetic markers for the same and additional
forensic purposes in the future.
4. Conclusions
For the ﬁrst time, we demonstrate the feasibility of parallel
sequencing analysis of various nucleic acid markers of different
types (i.e., STRs, amelogenin insertion/deletion, and mRNAs) for
different forensic purposes (i.e., individual, sex, and tissue
identiﬁcation) simultaneously, and present the Ion Torrent PGM
as a suitable platform to achieve this goal. Given the proof-of-
principle nature of our study, it is up to future studies to investigate
more forensically relevant aspects such as sensitivity, robustness,
and reliability, and other elements of a formal forensic develop-
mental validation study. Future work is aimed to increase the
number of forensic STR loci included in the system, and to modify
the RNA/cDNA primers allowing a fully parallel analysis protocol.
Moreover, in the future, the suitability of the Ion Torrent PGM
platform in combining targeted sequencing of different types of
nuclear acid markers for different forensic purposes shall be
further expanded, such as by additionally adding appearance and
ancestry predicting SNPs for investigating purposes for cases
where the generated STR proﬁle does not match any known
person. Eventually, we envision a targeted NGS tool that combines
nucleic acid markers of different types for all relevant forensic
purposes in a single analysis to provide a highly effectivemolecular
tool to improve forensic investigation, especially in cases where
the evidencematerial is highly limited and not enough for a battery
of independent tests. Future work will show if the currently
available NGS technologies and machineries, such as Ion Torrent
PGMare already suitable to achieve such all-in-one forensic tool, or
if further developments in sequencing technologies have to be
awaited to achieve this ambitious goal.
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